The present invention is directed to methods of probiotic selection and use based on the capability of microbial biogenic amine uptake as a method for targeted clinical and veterinary applications, including promoting health and well-being and/or treating therapeutic conditions. The present invention utilizes a microbially-focused approach for the development of drug selection and/or probiotic administration in a variety of diseases and disorders.
                            本发明涉及基于微
生物生物胺吸收能力的益生菌选择和使用方法,作为一种有针对性的临床和兽医应用方法,包括促进健康和福祉和/或治疗条件。本发明利用一种以微
生物为重点的方法来开发各种疾病和失调的药物选择和/或益生菌给药。